Excited to share with all our latest work on the use of single cell tools in following IDH mutant AML patients during their treatment! Out today Cell Stem Cell !! An amazing collaboration with AK Eisfeld & Elli Papaemmanuil, PhD & Dan Landau !!! Driven by the impressive Maria Sirenko

Adoptive natural killer (NK) cell therapy may have a role to play in clonal cytopenia of unknown significance (CCUS) and could help prevent CCUS patients from developing myelodysplastic syndrome (#MDS) & #AML #leukemia NK immune cells derived from pre-leukemic bone marrow stem

NEW RESEARCH—A retrospective cohort study from the UK reports treatment outcomes of targeted therapies in patients with #VEXAS syndrome thelancet.com/journals/lanrh… Taryn Youngstein James Poulter

Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade: Cell Reports Medicine cell.com/cell-reports-m…

To be cited in #EHA2025 by #mdsm experts ! Proud #VEXAS

🔥 POS1124 | A major step for #VEXAS: an international expert panel reached consensus on the definition of a VEXAS flare using Delphi methodology. ➡️3 categories, adjudication pathway, and a clear criterion: GC escalation. Crucial for trials, therapy, and patient care. #EULAR2025

It was an honor to present on behalf the Frenvex our results on Aza in #VEXAS syndrome at #EHA2025

Long awaited results of #VERONA (PH3 of aza-ven vs aza) in higher risk MDS press release with negative top line results for OS. We unfortunately remain in the dreaded boulevard of broken dreams in higher risk #MDSsm. Subgroup analyses will be important. news.abbvie.com/2025-06-16-Abb…

It’s online ! Happy to share with you: Incidence and burden of lower-risk myelodysplastic syndrome: a nationwide population study - Clinical Lymphoma, Myeloma and Leukemia clinical-lymphoma-myeloma-leukemia.com/article/S2152-…

Join us for a 2-hour post #ASCO25 & #EHA25 @vjhemonc updates in #MDSsm of the most important abstracts delivered in abbreviated format by the authors themselves & then discussed by panels of experts. Register at Post-EHA 2025 MDS Highlights | VJHemOnc vjhemonc.com/event/post-eha…

📢 New multicentre real‑life study by the GFM now published in British Journal of Haematology! 🩸 #mds #mdsm #gfm British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/bj…

doi.org/10.1002/ajh.27… Durable Responses with Front-line Rituximab in Autoimmune Cytopenias associated with indolent B-cell clones Now online in AmericanJournalofHematology Well done Yoann Zadro

MAIN SCIENTIFIC TOPICS OF #ESHMDS2026 More information➡ bit.ly/4lpZ7yA 10th Translational Research Conference Myelodysplastic Syndromes, Overlap MDS/MPN Disorders & Clonal Hematopoiesis Chairs: FENAUX Pierre katharina goetze Mikkael A. Sekeres MD, MS Oct 16-18, 2026 #ESHCONFERENCES

For anyone interested in #VEXAS check out the 2nd international workshop happening Sept NYU Langone Health in NYC. Peter Grayson Bhavisha Patel Siniša Savić Sophie Georgin-Lavialle Mikkael A. Sekeres MD, MS Thibault Comont, MD Benjamin Terrier highmarksce.com/nyumc/index.cf…

NEW! ACR has published guidance statements as a resource for clinicians managing patients with suspected/confirmed VEXAS. These guidance statements offer practical advice on several key topics & provide considerations for management of the disease. VIEW → acr.tw/4liZrhh

Excited to see these finally published! American College of Rheumatology guidance statement for diagnosis and management of #VEXAS. A major international effort! acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS - Developed by the International VEXAS Working Group Expert Panel Figure: A practical treatment algorithm for clinical management of VEXAS syndrome based on current available evidence

novartis.com/news/media-rel…

American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel - Mekinian - Arthritis & Rheumatology - Wiley Online Library acrjournals.onlinelibrary.wiley.com/doi/10.1002/ar…

Arvind Kaul Austin Kulasekararaj Siniša Savić Mapping the infectious burden in VEXAS syndrome: a systematic review and rationale for prevention Valentine Ribier and colleagues characterise the infectious burden of VEXAS syndrome and propose preventive strategies bit.ly/3VDJIPq